World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN (O) : 2455-3301
ISSN (P) : 3051-2557
IMPACT FACTOR: 7.533

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , Doi-Digital Online Identifier , ISSN National Centre , Zenodo Indexing , International CODEN Service, USA , 

SJIF Impact Factor: 7.533

Abstract

BIOAVAILABILITY VS CONVENIENCE: A COMPARATIVE PHARMACEUTICO-CLINICAL ANALYSIS OF CHURNA (POWDER) AND VATI (TABLET) DOSAGE FORMS IN AYURVEDIC THERAPEUTICS

*Dr. Parveen Fatima, Dr. Himanshu Saini, Dr. Varun Kumar, Dr. Ankita Yadav

ABSTRACT

The modernization of Ayurvedic pharmaceutics has seen a massive shift from traditional powders (Churna) to compressed tablets (Vati/Gutika), driven primarily by patient compliance and convenience. However, this shift raises critical pharmacokinetic questions regarding efficacy, onset of action, and bioavailability. This paper analyzes the comparative pharmacodynamics of Churna and Vati, exploring the "Convenience Tax"—the potential loss of therapeutic potency due to compression, excipients, and the bypassing of oral sensory signaling (Rasa-Bodhana). We argue that for specific therapeutic indications, particularly Deepana (appetizer) and Pachana (digestive), the tablet form significantly compromises clinical outcomes.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR